CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

ConferencePositive
AI Analysis

Summary

Rein Therapeutics announced it will present a late-breaking poster at the European Respiratory Society 2026 Congress in Barcelona, Spain, September 5-9, 2026, related to its novel pulmonary and fibrosis medicines pipeline.

Outcome Details

Late-breaking poster presentation at European Respiratory Society (ERS) 2026 Congress

Importance:3/10
Sentiment:
0.30
conferenceposter presentationpulmonaryfibrosisorphan indication
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 4, 2026 12:00 PM

Read Original